You MISINTERPRET the posted information. There is no "bias opinion". The post I assume you are referring to is a link to factual competition updating the market about the completion of their Phase 2 clinical trial. The quote from management is based on scientific evidence from comparator pre clinical trial data. If you can't stand on data and instead label it opinionated I'm not sure why anyone is invested in a clinical trial biotech company(?). Like I previously stated, the post is new and relevant information. Bill Gates is one monkey that's obviously not stopping the Algernon show. Another monkey won't do it either. We know tons more Algernon news is forthcoming. Meanwhile, I'll keep posting relevant information for investors interested in seeing what maybe around the pending corners.
As Chris Moreau stated about BELLUS
Here we have a very clean pure comparator example
Before Chris told everyone about BELLUS most likely never heard of the Canadian company. It seems like knowing what BELLUS is up to is a good roadmap to follow. Ya think?! - rhetorically speaking of course.
News 
Market Data 
Discover 
